SEATTLE, Feb. 26, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network
dedicated to legal cannabis, announces publication of an article covering RavenQuest BioMed Inc.’s (CSE:RQB) (CNSX:RQB) (CSE:RQB.CN) strategic approach to national
growth. The company is a great example of a diversified cannabis company with its four pillars approach to the industry. Recent
developments have greatly accelerated the company’s progress on a number of fronts. With near-term licensed production expected to
come online to coincide with the coming federal legalization of adult recreational cannabis use, investors may want to take a
closer look at the stock.
Four Pillars Approach
RavenQuest BioMed has developed a four pillars approach to the cannabis industry to generate both near- and long-term value for
shareholders.
- Indigenous Peoples Traction - The Company provides a turnkey solution for the production and sale of cannabis on sovereign
land. Under the guidance of Bill Robinson, a 34-year veteran of the Royal Canadian Mounted Police, the company has already
identified and engaged with an impressive list of prospective partners. RavenQuest was recently selected as the sole industry participant at recent province-wide meetings on Indigenous participation
in the cannabis industry. Over 120 leaders from Indigenous communities across the Province of Saskatchewan were in attendance
with extremely positive feedback. A significant number of those in attendance expressed immediate interest in further discussion.
- Production and Sale of Cannabis (Investment Division) - In addition to 100% ownership in late-stage applicant, Alberta Green
Biotech, RavenQuest also just announced a binding
letter of intent to acquire an existing licensed producer in Ontario. Both deals are discussed in detail below.
- Research and Development - The Company’s partnership with top-ranked McGill University targets maximized flower production,
cultivar recognition and stabilization of the cannabis plant. The plant breeders’ rights that result from the research can be
applied to its own operations and sold to other licensed producers industrywide.
- Management Services - Even prior to full legalization and production begins, RavenQuest is cash-flow positive, unique for an
early-stage growth company and reassuring to investors. The company has already provided consulting services to eleven
licensed producers and helped them navigate the complex and demanding Health Canada licensing process. With a steady pipeline of
management service contracts, the company generates revenue right now while building new partnerships. The services
division also acts as a natural source of deal flow for the Investment Division, as it is likely that many existing services
clients will become friendly acquisitions when RavenQuest sees a strategic fit and opportunity.
The combination of near-term revenue and long-term potential sets the company apart from competitors in the cannabis
industry.
Mergers & Acquisitions
In late January, RavenQuest BioMed announced a binding letter of intent to purchase Bloomera, a licensed producer of medical
cannabis located in the Greater Toronto Area. Under the terms of the LOI, the company agreed to acquire all of the outstanding
share capital of Bloomera.
Bloomera holds an active Health Canada License to cultivate with up to 4,000,000 grams of production capacity. More importantly,
the acquisition accelerates the company’s growth strategy by at least six months and opens the door to a much faster growth
trajectory moving forward. The Bloomera facility is strategically located, providing access to Ontario’s 13 million residents and
largest population centre of 6.4 million in Toronto alone. This is an important provincial presence because cannabis distribution
will be controlled by central distributors in each of Canada’s provinces.
RavenQuest’s new central Canadian acquisition broadens the company’s national reach and compliments its existing presence in
western Canada. Alberta Green Biotech Inc., an aspiring licensed producer based in Edmonton, will have capacity of about 7,000,000
grams per year. Facility construction is expected to be completed and ready to produce by mid-2018 to coincide with federal
legalization of recreational marijuana, creating a near-term catalyst for shareholders.
Combined, the two deals give RavenQuest geographic diversification across Canada, including a licensed presence in the country’s
most populous province, Ontario.
Looking Ahead
RavenQuest BioMed Inc. (CSE:RQB) represents a compelling investment opportunity in Canada’s burgeoning cannabis industry. With a
four pillar approach to the market, the company offers both near- and long-term potential to investors. Its acquisition of two
cultivation properties also opens the door to near-term cultivation and production opportunities later this year. Investors
interested in the space may want to take a closer look at the company.
For more information, visit the company’s website or download their investor presentation.
Please follow the link to read the full article:
http://www.cannabisfn.com/ravenquest-accelerates-national-growth-strategy-acquires-toronto-area-licensed-producer/RQ
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana
businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and
brands in the US and Canada rely on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own
independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com(the ‘Site’) is either original financial news or paid
advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm
enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other
editorials for advertising such companies. We are not an independent news media provider. We make no warranty or
representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly
and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As
such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted.
CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along
with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create
awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
Contact Information:
Frank Lane
206-369-7050
flane@cannabisfn.com
